Soquimich Comercial S.A. (SNSE:SOQUICOM)

ASLAN Pharmaceuticals Ratios and Metrics

Market cap in millions CLP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	106,667	77,025	69,787	92,520	60,121	58,758
Market Cap Growth	9.84%	10.37%	-24.57%	53.89%	2.32%	34.75%
Enterprise Value	79,414	66,030	60,582	88,212	34,399	26,481
Last Close Price	391.99	261.42	213.38	247.72	132.39	99.70
PE Ratio	12.23	8.81	8.16	7.71	4.69	10.94
PS Ratio	0.82	0.57	0.58	0.68	0.44	0.70
PB Ratio	1.67	1.16	1.20	1.64	1.06	1.03
P/TBV Ratio	1.68	1.16	1.20	1.64	1.05	1.02
P/FCF Ratio	21.78	7.28	4.90	-	4.54	2.73
P/OCF Ratio	19.29	6.77	4.52	-	4.37	2.72
EV/Sales Ratio	0.61	0.49	0.50	0.65	0.25	0.32
EV/EBITDA Ratio	6.10	5.40	5.12	4.81	1.83	3.03
EV/EBIT Ratio	6.91	5.56	5.25	4.90	1.86	3.20
EV/FCF Ratio	16.21	6.24	4.26	-	2.60	1.23
Debt / Equity Ratio	0.04	0.05	0.07	0.07	0.08	0.06
Debt / EBITDA Ratio	0.21	0.23	0.30	0.19	0.23	0.37
Debt / FCF Ratio	0.55	0.29	0.27	-	0.34	0.17
Asset Turnover	1.20	1.23	1.17	1.25	1.19	0.86
Inventory Turnover	3.22	3.92	3.03	3.22	3.85	3.38
Quick Ratio	1.39	1.82	1.78	1.33	1.37	1.86
Current Ratio	2.25	2.54	2.62	2.18	2.05	2.50
Return on Equity (ROE)	13.68%	13.16%	14.65%	21.22%	20.60%	8.55%
Return on Assets (ROA)	6.62%	6.78%	7.00%	10.32%	10.11%	5.31%
Return on Capital (ROIC)	10.71%	10.58%	11.58%	18.56%	17.26%	7.83%
Return on Capital Employed (ROCE)	17.30%	17.00%	18.50%	29.80%	30.30%	13.60%
Earnings Yield	8.18%	11.35%	12.25%	12.97%	21.34%	9.14%
FCF Yield	4.59%	13.73%	20.40%	-5.14%	22.03%	36.64%
Dividend Yield	8.80%	-	14.72%	17.80%	35.61%	32.89%
Payout Ratio	107.02%	110.80%	146.87%	103.09%	47.85%	73.58%
Total Shareholder Return	8.85%	-	14.72%	17.80%	35.61%	32.89%

Updated Nov 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.